A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

BackgroundThe development of a medicine is not only underpinned by good science but also by Quality DecisionMaking Practices (QDMPs). Indeed, it is important to ensure that all organisations involved in the lifecycle of medicines are aligning their practices in decision-making to the QDMPs to ensure...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Magdalena Bujar (लेखक), Neil McAuslane (लेखक), Stuart Walker (लेखक), Sam Salek (लेखक)
स्वरूप: पुस्तक
प्रकाशित: Kerman University of Medical Sciences, 2022-02-01T00:00:00Z.
विषय:
ऑनलाइन पहुंच:Connect to this object online.
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_012254db8d8243e3bca7d76701cfb7f2
042 |a dc 
100 1 0 |a Magdalena Bujar  |e author 
700 1 0 |a Neil McAuslane  |e author 
700 1 0 |a Stuart Walker  |e author 
700 1 0 |a Sam Salek  |e author 
245 0 0 |a A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines 
260 |b Kerman University of Medical Sciences,   |c 2022-02-01T00:00:00Z. 
500 |a 2322-5939 
500 |a 10.34172/ijhpm.2020.86 
520 |a BackgroundThe development of a medicine is not only underpinned by good science but also by Quality DecisionMaking Practices (QDMPs). Indeed, it is important to ensure that all organisations involved in the lifecycle of medicines are aligning their practices in decision-making to the QDMPs to ensure quality, transparent and consistent decisionmaking processes.MethodsThe aim of this study was to evaluate the practicality of QoDoS (Quality of Decision-Making Orientation Scheme) in assessing the incorporation of ten QDMPs during the development, review and reimbursement of medicines, illustrated by case studies with a pharmaceutical company, a regulatory authority and a health technology assessment (HTA) agency. Individuals from each organisation completed the 47-item QoDoS questionnaire.ResultsThe results demonstrate the applicability of QoDoS in identifying favourable and unfavourable practices and in assessing the consistency and transparency of the QDMPs within each organisation, as well as across the different stakeholders. Furthermore, the study established the value of the methodology in raising awareness of the biases and best practices in decision-making, as well as having a basis for discussion for differences within and across stakeholders to promote consistency and alignment in decision-making. Finally, the QoDoS demonstrated the need for improvement across a number of decision-making practices for the 3 organisations such as the evaluation of alternatives and of the decision impact.ConclusionThe QoDoS can be used to benchmark organisations' decision-making practices to provide a basis for discussion to ultimately encourage a level of trust across and within organisations and helping to identify areas for improvement. 
546 |a EN 
690 |a quality decision-making 
690 |a qodos, medicines development 
690 |a regulatory review 
690 |a health technology assessment 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n International Journal of Health Policy and Management, Vol 11, Iss 2, Pp 128-137 (2022) 
787 0 |n https://www.ijhpm.com/article_3832_df04017cfbe6c51c03f94f048ae45406.pdf 
787 0 |n https://doaj.org/toc/2322-5939 
856 4 1 |u https://doaj.org/article/012254db8d8243e3bca7d76701cfb7f2  |z Connect to this object online.